Gary S. Gillheeney - 30 Jun 2022 Form 4 Insider Report for Organogenesis Holdings Inc. (ORGO)

Role
President and CEO, Director
Signature
/s/ William R. Kolb, Attorney-in-Fact
Issuer symbol
ORGO
Transactions as of
30 Jun 2022
Net transactions value
+$500,000
Form type
4
Filing time
01 Jul 2022, 17:03:37 UTC
Previous filing
03 Jun 2022
Next filing
17 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORGO Class A Common Stock Options Exercise $500,000 +505,050 +127% $0.9900 903,292 30 Jun 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORGO Stock Option (Right to Buy) Options Exercise $0 -505,050 -100% $0.000000* 0 30 Jun 2022 Class A Common Stock 505,050 $0.9900 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the shares subject to the option are fully vested and exercisable.